Tower Research Capital (TRC)’s PepperLime Health Acquisition Corporation Unit PEPLU Stock Holding History

Tower Research Capital (TRC)’s Portfolio PEPLU Stock Details PEPLU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-7,548	Closed	-$76K	–	6813
2022 Q4	$76K	Hold	7,548	–	–	﹤0.01%	2043
2022 Q3	$75K	Hold	7,548	–	–	﹤0.01%	2819
2022 Q2	$74K	Hold	7,548	–	–	﹤0.01%	2533
2022 Q1	$76K	Hold	7,548	–	–	﹤0.01%	2402
2021 Q4	$74K	Buy	+7,548	New	+$75.4K	﹤0.01%	2454

Other funds holding PEPLU

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

Tower Research Capital (TRC)'s PEPLU Position: Q1 2023 in Review

Tower Research Capital (TRC) sold out of PepperLime Health Acquisition Corporation Unit (PEPLU) in Q1 2023, closing a stake of 7,548 shares — an estimated $76K sold.

Tower Research Capital (TRC) first reported a position in PEPLU in Q4 2021 and held it in 5 quarters. The position peaked at $76K in Q4 2022. 1 fund tracked by Wall St. Rank holds PEPLU as of Q1 2023.

Tower Research Capital (TRC) reported no remaining PepperLime Health Acquisition Corporation Unit position as of Q1 2023 after selling out during the quarter.
Tower Research Capital (TRC) sold 7,548 PepperLime Health Acquisition Corporation Unit shares in Q1 2023, an estimated $76K.
Tower Research Capital (TRC) first reported a position in PepperLime Health Acquisition Corporation Unit in Q4 2021 and held it in 5 quarters.
Tower Research Capital (TRC)'s PepperLime Health Acquisition Corporation Unit position peaked at $76K in Q4 2022.
1 fund tracked by Wall St. Rank held PepperLime Health Acquisition Corporation Unit as of Q1 2023.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2023, filed 9 May 2023.